Clinical trial · Interventional
The Application of Invivo Microscopy Imaging in the Early Diagnosis of Cervical Cancer
NCT02955667CI-TRIAL-00024726unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study intends to carry out a prospective, randomized controlled trial to research and development a new invivo microscopy based on the technology which is combined with high-definition microscopy and colposcopy，so as to diagnose cervical lesion directly and non-invasively by observing cervical tissues and cells, which makes it possible to diagnose cervical cancer without wounds.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Cervical Precancer | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| invivo microscopy group | Procedure | — | UNRESOLVED |
| normal group | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- invivo microscopy group
- description
- patients receive invivo micro-colposcopy examination and do not have to receive the biopsies
- interventionNames
- Procedure: invivo microscopy group
- type
- OTHER
- label
- normal group
- description
- patients receive normal colposcopy examination and the biopsy specimens are sent for pathological HE staining and analysis
- interventionNames
- Procedure: normal group
Primary outcomes (1)
- measure
- diagnostic accuracy rate
- timeFrame
- 1 day (time of the examination)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: 1. cervical cytologic test result is HSIL 2. persistent infection with high-risk HPV 3. cervical pathological diagnosis is LSIL or HSIL Exclusion Criteria: 1. acute infection of lower genital tract 2. the wound in lower genital tract 3. active bleeding in lower genital tract
References
Publications (0)
Data not yet available
No reference posted for this study.